Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epitope selection and design of synthetic vaccines. Molecular approaches to enhancing immunogenicity and cross-reactivity of engineered vaccines.

× No keyword cloud information.

13 in total

Review 1. Progress on new vaccine strategies for the immunotherapy and prevention of cancer.

Authors: Jay A Berzofsky; Masaki Terabe; SangKon Oh; Igor M Belyakov; Jeffrey D Ahlers; John E Janik; John C Morris
Journal: J Clin Invest Date: 2004-06 Impact factor: 14.808

Review 2. Strategies to use immune modulators in therapeutic vaccines against cancer.

Authors: Jay A Berzofsky; Masaki Terabe; Lauren V Wood
Journal: Semin Oncol Date: 2012-06 Impact factor: 4.929

3. F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.

Authors: C Liu; J Goldstein; R F Graziano; J He; J K O'Shea; Y Deo; P M Guyre
Journal: J Clin Invest Date: 1996-11-01 Impact factor: 14.808

4. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

Authors: P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky
Journal: J Clin Invest Date: 1998-09-15 Impact factor: 14.808

5. Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.

Authors: J D Ahlers; T Takeshita; C D Pendleton; J A Berzofsky
Journal: Proc Natl Acad Sci U S A Date: 1997-09-30 Impact factor: 11.205

Review 6. Cancer vaccines: translation from mice to human clinical trials.

Authors: Hoyoung Maeng; Masaki Terabe; Jay A Berzofsky
Journal: Curr Opin Immunol Date: 2018-03-16 Impact factor: 7.486

7. TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.

Authors: Lauren V Wood; Antonio Fojo; Brenda D Roberson; Meghan S B Hughes; William Dahut; James L Gulley; Ravi A Madan; Philip M Arlen; Marianna Sabatino; David F Stroncek; Luciano Castiello; Jane B Trepel; Min-Jung Lee; Howard L Parnes; Seth M Steinberg; Masaki Terabe; Julia Wilkerson; Ira Pastan; Jay A Berzofsky
Journal: Oncoimmunology Date: 2016-07-01 Impact factor: 8.110

Review 8. Vaccine therapy for cancer.

Authors: D C Linehan; P S Goedegebuure; T J Eberlein
Journal: Ann Surg Oncol Date: 1996-03 Impact factor: 5.344

Review 9. DNA vaccines: developing new strategies against cancer.

Authors: Daniela Fioretti; Sandra Iurescia; Vito Michele Fazio; Monica Rinaldi
Journal: J Biomed Biotechnol Date: 2010-03-28

10. Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.

Authors: Toshi Nagata; Yukio Koide
Journal: J Biomed Biotechnol Date: 2010-05-24